Li Cao
- Molecular Biology
- Cardiology and Cardiovascular Medicine top 10%
- Organic Chemistry top 10%
- Oncology
- Pharmacology top 10%
- Co-authors
- David G. GardnerLei WangA. James LinkJianming WuTruc DoBingchen YuJun LiuHader E. Elashal
- Topics
- Peptidase Inhibition and Analysis (7 papers)Monoclonal and Polyclonal Antibodies Research (7 papers)Click Chemistry and Applications (7 papers)
- Partner nations
- United StatesChinaGermany
In The Last Decade
Li Cao
33 papers receiving 899 citations
Peers
Comparison fields: 5 of 83
- Molecular Biology 483
- Cardiology and Cardiovascular Medicine 285
- Organic Chemistry 168
- Oncology 123
- Pharmacology 108
Countries citing papers authored by Li Cao
This map shows the geographic impact of Li Cao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Li Cao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Li Cao more than expected).
Fields of papers citing papers by Li Cao
This network shows the impact of papers produced by Li Cao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Li Cao. The network helps show where Li Cao may publish in the future.
Co-authorship network of co-authors of Li Cao
This figure shows the co-authorship network connecting the top 25 collaborators of Li Cao. A scholar is included among the top collaborators of Li Cao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Li Cao. Li Cao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 11 | |
| 3 | 1 | |
| 4 | 22 | |
| 5 | 1 | |
| 6 | 11 | |
| 7 | 30 | |
| 8 | 40 | |
| 9 | 22 | |
| 10 | 74 | |
| 11 | 66 | |
| 12 | 4 | |
| 13 | 8 | |
| 14 | 15 | |
| 15 | 5 | |
| 16 | 23 | |
| 17 | 3 | |
| 18 | 69 | |
| 19 | 231 | |
| 20 | 14 |
About Li Cao
Li Cao is a scholar working on Organic Chemistry, Cardiology and Cardiovascular Medicine and Molecular Biology, having authored 36 papers that have together received 908 indexed citations. Recurring topics across this work include Peptidase Inhibition and Analysis (7 papers), Monoclonal and Polyclonal Antibodies Research (7 papers) and Click Chemistry and Applications (7 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (285 citations), Microbiology (46 citations) and Molecular Biology (483 citations). Li Cao has collaborated with scholars based in United States, China and Germany. Frequent co-authors include David G. Gardner, Lei Wang, A. James Link, Jianming Wu, Truc Do, Bingchen Yu, Jun Liu, Hader E. Elashal, Paul C. Klauser and Nanxi Wang. Their work appears in journals such as Chemical Reviews, Journal of the American Chemical Society and Journal of Biological Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.